Eurazeo has announced an investment of $75 million in direct-to-consumer (D2C) design medical apparel company Jaanuu, according to a Tuesday (Jan. 11) press release.
Jaanuu, which comes from the Hindi word for life, was founded in 2013. Its goal is to provide healthcare professionals with modern apparel to help them perform better. With Eurazeo’s investment, Jaanuu’s capital will now sit at $100 million.
The company’s work is looking into changing the usual legacy brands for medical apparel, and Jaanuu is trying to offer better fit, fabrics, functionality and comfort with digital access channels.
Jaanuu has been investing in its leadership team and plans to grow more this year. Through this partnership, the company plans to support brand marketing investments to help with awareness and drive trial, along with continuing to invest in product innovation.
Eurazeo plans to leverage its global network to help Jaanuu grow its customer base and geographical footprint.
“We are excited to continue supporting all the healthcare professionals that put other people’s needs ahead of their own each and every day,” said Jaanuu co-founder and CEO Shaan Sethi. “We created Jaanuu to provide healthcare professionals with scrubs offering superior design, comfort and performance, enabling them to provide better patient service. We are excited to partner with Eurazeo to increase our brand awareness and accelerate our global growth.”
Advertisement: Scroll to Continue
Meanwhile, Jill Granoff, Eurazeo managing partner and Eurazeo Brands CEO, called Jaanuu “an authentic, doctor-led, digitally-native brand that is disrupting the traditional medical apparel market by delivering high-performing modern scrubs with the convenience of online shopping.”
PYMNTS wrote that Eurazeo was also involved in helping fund payroll and human resources management solution PayFit.
See also: PayFit Raises $276M to Transform HR Technology
PayFit raised 254 million euros overall in the round last year, which was a record-breaking amount for the Paris-based company.
The company was valued at $2 billion and said its mission was to keep getting stronger in its markets, including recruiting more staff, boosting its product development and improving European market share.
